Company news
Medical Developments International Limited news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Penthrox is launched in Italy
October 22, 2019
Positive study results for Penthrox
October 21, 2019
Penthrox USA Update
July 19, 2019
Licensing deal for Penthrox in Australia
June 2, 2019
FY19 Half Year Report and Accounts
February 19, 2019
Trading and market update
October 30, 2018
Penthrox approved in Hong Kong
October 22, 2018
Penthrox is approved in Saudi Arabia
October 11, 2018
MVP signs exclusive Penthrox deal for China
October 7, 2018
Penthrox Paediatric Trial Safety Update
August 29, 2018
Cleansing Notice and Appendix 3B
August 14, 2018
Capital Raising - Placement and Share Purchase Plan
August 8, 2018
FY18 Results Update
August 6, 2018
USA Update
July 25, 2018
Penthrox approved in Spain
July 16, 2018
Penthrox approved in Italy and the Czech Republic
July 9, 2018
Penthrox approved in Portugal and Switzerland
June 25, 2018
Iran Distribution Deal and additional European Approvals
May 29, 2018
Trading Update
May 14, 2018
Penthrox Approved in Finland
April 24, 2018
Penthrox is approved in Canada
April 10, 2018
Penthrox approved in Germany
April 5, 2018
Penthrox approved in Sweden, Norway, Poland and Croatia
March 26, 2018
Global demand for Medical Developments Shares
March 19, 2018
Stage II success for new manufacturing technology- Lidocaine
February 20, 2018
First Penthrox order for Austria
February 18, 2018
Half Year Report and Accounts
February 15, 2018
MVP signs major deal with Walgreens in the USA
February 12, 2018
Penthrox approved in Latvia
February 9, 2018
Penthrox approved in Slovakia
February 1, 2018
Penthrox approved in Austria
January 29, 2018
Penthrox approved in Denmark
January 24, 2018
Penthrox approved in Iceland
January 22, 2018
Penthrox approved in another 22 European countries
December 11, 2017
Penthrox approved in Mexico
October 18, 2017
Chairman sells 4.35 million shares
October 15, 2017
Penthrox recommended for use in all UK ambulances
September 26, 2017
1st patient enrolled in Penthrox paediatrics trial in Europe
August 16, 2017
MVP signs Respiratory Device supply deal with Sams Club
August 2, 2017
Penthrox Regulatory Dossier accepted for review in Canada
June 15, 2017
MVP signs significant Development Project with CSIRO
June 4, 2017
Penthrox replaces Nitrous Oxide in New Zealand Ambulance
June 1, 2017
MVP Respiratory devices now available in USA Costcos
April 26, 2017
Penthrox Licensing Deal for Russia
April 11, 2017
MVPs Respiratory Devices in all Kmart pharmacies in the USA
April 10, 2017
MVPs Respiratory Devices in all Walmart stores in the USA
April 9, 2017
Penthrox Second order for UK and Ireland
March 1, 2017
Penthrox Launched in France and Belgium and first sales
February 7, 2017
Penthrox European Update
February 6, 2017
Penthrox approved for sale in Taiwan
December 7, 2016
Calls
Decks
The 5 newest of 50 decks. Every deck is listed under its year.
- FY2026 Earnings Presentation
Earnings · 18 slides · Aug 20, 2026
- H1 FY2026 Earnings Presentation
Earnings · 17 slides · Feb 19, 2026
- Shareholder Meeting (October 2025)
Shareholder meeting · 24 slides · Oct 10, 2025
- FY2025 Earnings Presentation
Earnings · 21 slides · Aug 21, 2025
- H1 FY2025 Earnings Presentation
Earnings · 19 slides · Feb 20, 2025